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commonly used as a diagnostic agent for the determina- 
tion of plasma volume. 5
The reason for inhibition of the sodium nitroprusside 
response by gentian violet is unclear. Gentian violet is 
metabolized to a reactive intermediate or free radical that 
could act at the vascular smooth muscle to inhibit the 
response. However, this is unlikely inasmuch as this 
mechanism would also interfere with the acetylcholine- 
mediated vasodilation. A more plausible explanation 
would be the formation of a reactive intermediate that 
interacts directly with the sodium nitroprusside molecule. 
In conclusion, although methylene blue has been used as 
a marker dye, our studies uggest that it is inappropriate for 
marking vascular grafts. Evans blue did not adversely affect 
vasodilation to any agent and thus could be used as an 
alternative to methylene blue without fear of affecting raft 
reactivity. Gentian violet also appears to be a better alternate 
to methylene blue. However, we did observe a decrease in 
endothelium-independent vasodilation, a factor that should 
be considered when this agent is used. 
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EROSION OF INLET CANNULA OF LEFT VENTRICULAR ASSIST DEVICE MANIFESTED AS 
INNOCUOUS BLEEDING IN STABLE PATIENT: LESSONS LEARNED IN PREVENTION OF 
CATASTROPHIC CONSEQUENCES 
Sanjay M. Mehta, MD, and Walter E. Pae, Jr., MD, Hershey, Pa. 
We present the case of a patient who underwent 
implantation of a left ventricular assist device (LVAD) as 
a bridge to transplantation a d subsequently had disrup- 
tion of the Dacron inflow graft of the pump. Surgical 
investigation at the development of expanding hematoma 
and drive line bleeding resulted in entrainment of air into 
the pump, massive air embolus, and subsequent death of 
the patient. We believe that this case demonstrates the 
need for angiographic definition of bleeding associated 
with a completely implanted LVAD before surgical explo- 
ration, as well as specific surgical strategies to avoid air 
embolus. 
A 64-year-old man was admitted to our institution with 
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a history of progressive cardiac failure. He had had aortic 
valve replacement with a porcine prosthesis and implan- 
tation of a pacemaker 7 years before this admission. An 
extensive valuation indicated end-stage dilated cardio- 
myopathy. The patient was activated on the waiting list for 
cardiac transplantation. Despite a regimen of dopamine, 
dobutamine, amrinone, and intravenous diuretics, the 
patient had progressive symptoms of cardiac failure. An 
intraaortic balloon pump was inserted, with only marginal 
improvement in hemodynamics. Despite this aggressive 
conventional management, he patient had progressive 
deterioration and thus underwent preperitoneal implan- 
tation 1'2 of the Thermo Cardiosystems Incorporated 
(TCI) Heartmate LVAD (Woburn, Mass.) 2 months after 
admission. The initial postoperative course was unevent- 
ful except for transient failure of the right side of the 
heart, responsive to dopamine, during the first postoper- 
ative week and thoracentesis on two occasions in the early 
postoperative course for recurrent left pleural effusion 
with drainage on each occasion of approximately 1 L of 
serous fluid. On postoperative day 32 the patient was 
evaluated on an emergency basis for brisk bleeding 
around the drive line site, and physical examination 
confirmed an expanding collection of fluid within the 
preperitoneal implantation pocket. The patient was 
promptly taken to the operating room for suspected 
bleeding within the preperitoneal pocket. The preperito- 
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Fig. 1. Probe shows site of erosion along inlet cannula 
owing to displacement of overlying protective cage. 
neal pocket was opened and noted to have a collection of 
approximately 2 L of dark clotted blood. This collection 
was removed to identify the underlying bleeding site, 
which was quickly identified to be a defect in the inlet 
cannula of the pump. The patient's chest was promptly 
opened and cardiopulmonary b pass initiated. The pump 
was stopped and the cannula evaluated. Unfortunately, 
despite rapid and aggressive intervention, the patient's 
heart, aorta, and pump were noted to be filled with 
entrained air. The patient died shortly thereafter in the 
operating room. 
An autopsy subsequently revealed that the cage support 
had eroded through and resulted in a 2 cm laceration in 
the Dacron inlet graft (Fig. 1). This laceration was located 
at the level of the diaphragm, with consequent subdia- 
phragmatic blood collection, likely the source of the 
recurrent serous pleural effusions on that side. No other 
abnormalities associated with the pump or its implanta- 
tion were noted at that time. 
To our knowledge this is the first case of its kind that 
has been reported in the literature. After this event, 
personal comraunication has revealed that other institu- 
tions have had similar problems with the inlet cannulas, 
which subsequently resulted in a design change and 
voluntary recall of the inlet assembly by TCI. 
A patient who has periodic or persistent bleeding at any 
time after implantation should be treated with the utmost 
caution; however, as the time after implantation i creases, 
bleeding is less likely to be a function of surgical tech- 
nique. The initial management of these patients should be
centered on aggressive r suscitation, including transfusion 
as necessary, and correction of any aberrations in coagu- 
lation factors. Early angiographic evaluation is warranted 
to avoid progressive problems with these patients. Angiog- 
raphy should reveal any large breaks in the integrity of the 
pumping system. 
A diagnostic angiogram, a nondiagnostic study with 
persistent evidence of bleeding, or a patient whose con- 
dition is too unstable to tolerate angiographic evaluation 
warrants immediate operative xploration. However, all 
care must be taken to control the device during the 
evaluation to prevent potential entrainment of air within 
the system, as has been previously described for explan- 
tation of these devices at the time of transplantation. 3 
These patients are dependent on augmented flow from 
these devices to sustain adequate perfusion. Hence wean- 
ing from the device before exploration is not a feasible 
option in most patients. The safest approach appears to be 
aggressive intervention by initiation of femoral-femoral 
cardiopulmonary bypass, thus allowing cessation of 
LVAD pumping before wide exploration of the circuit, 
anastomotic sites, and pockets. Any necessary interven- 
tions including complete pump replacement may then be 
undertaken while the patient is maintained with cardio- 
pulmonary bypass. 
Although this intervention may appear excessive for an 
unclear cause of bleeding, our case demonstrates that 
these patients may have significant problems with circuit 
continuity of the LVAD without manifesting significant 
clinical symptoms. Therefore we believe that early and 
aggressive management is warranted, because the conse- 
quences of exploration can prove devastating. 
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